Verastem (VSTM) Interest Coverage Ratio (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.61% |
| Dec 31, 2025 | 259.84% |
| Sep 30, 2025 | 70.84% |
| Jun 30, 2025 | -90.22% |
| Mar 31, 2025 | -734.64% |
| Dec 31, 2024 | 14.54% |
| Sep 30, 2024 | -100.84% |
| Jun 30, 2024 | 35.32% |
| Mar 31, 2024 | 10.69% |
| Dec 31, 2023 | -47.31% |
| Sep 30, 2023 | -4.27% |
| Jun 30, 2023 | 28.04% |
| Mar 31, 2023 | -8.11% |
| Dec 31, 2022 | 5.79% |
| Sep 30, 2022 | 26.14% |
| Jun 30, 2022 | 88.97% |
| Mar 31, 2022 | 81.64% |
| Dec 31, 2021 | -88,649.68% |
| Sep 30, 2021 | 88.25% |
| Jun 30, 2021 | -9.42% |
| Mar 31, 2021 | -16.94% |
| Dec 31, 2020 | -256.39% |
| Sep 30, 2020 | 169.51% |
| Jun 30, 2020 | -360.96% |
| Mar 31, 2020 | 59.55% |
| Dec 31, 2019 | -17.90% |
| Sep 30, 2019 | 29.86% |
| Jun 30, 2019 | -4.95% |
| Mar 31, 2019 | 18.86% |
| Dec 31, 2018 | 65.36% |
| Sep 30, 2018 | 29.03% |
| Jun 30, 2018 | 18.48% |
| Mar 31, 2018 | 21.41% |
| Dec 31, 2017 | 73.83% |
| Sep 30, 2017 | -70.24% |
| Jun 30, 2017 | 88.72% |